GL1X · GenesisL1 explorer

MolNFT v1 · #123117 · protein

Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914

5JA7: “Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914”. X-ray diffraction, 2 ligands (6HM, SO4), 1 pocket (best druggability 0.54). MolNFT v1 #123117 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
5JA7
Type
protein
Length
445 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin K
EC
3.4.22.38
UniProt
P43235
Ligands
6HM, SO4
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACathepsin K (EC 3.4.22.38)protein22227% helix, 23% strandP43235
BCathepsin K (EC 3.4.22.38)protein22327% helix, 22% strandP43235

Ligands and binding sites

  • 6HM · [([1,1'-biphenyl]-2-yl)methyl]propanedioic acid · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • GOL · Glycerol · additive · chains B
  • ACT · Acetate ion · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13290.540.75346HM

Interfaces

1 interface between chains.

  • A–B · 87 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 5JA7 · Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914 · the same entry in another collection · chain A against A, TM-score 1.00
  • P43235 · AlphaFold monomer V2.0 prediction for cathepsin K (P43235) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.